Add to ORKGAcamprosate was shown to help to maintain abstinence on alcoholic patients. In this paper, we show that acamprosate has the secondary effect to reduce consumption. These results obtained from an Individual Patient Data Meta-Analysis.Test de la reduction de consommation pour des patients alcoo-dépendants, via une meta-analyse réalisée sur les données individuelles patient
We describe Efficacy and Safety of acamprosate in enhancing abstinence on detoxified patients, a met...
Acamprosate (calcium bis acetylhomotaurinate) is a new medication that appears to be clinically usef...
general study on compliance conditions throughout a meta-analysis of 4354 patients treated with acam...
In this review, acamprosate effect in reducing consumption was assessed with an IPD meta-analysi
An assessment of the efficacy of treatment with acamprosate was, therefore, undertaken using meta-an...
Data on patients' alcohol consumption from 15 placebo-controlled treatment studies (n = 3309) were e...
Acamprosate is an FDA-approved medication that enhances abstinence in alcohol-dependent patients. A ...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Review on literature on the effect of anti-addictive substance in enhancing abstinence of dependent ...
Naturalistic randomised study controlled against any other treatment to assess the effect of acampro...
Method: Randomized parallel groups prospective trial to assess the efficacy of nursing follow up of...
Abstract — Standard treatment for alcohol abuse may include pharmacotherapy to alleviate withdrawal ...
We compared effects of the standard 2 g dose (n=258) and an exploratory 3 g dose of acamprosate (n=8...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addicti...
To assess the effectiveness of pharmacotherapy with acamprosate in alcohol-dependent patients treate...
We describe Efficacy and Safety of acamprosate in enhancing abstinence on detoxified patients, a met...
Acamprosate (calcium bis acetylhomotaurinate) is a new medication that appears to be clinically usef...
general study on compliance conditions throughout a meta-analysis of 4354 patients treated with acam...
In this review, acamprosate effect in reducing consumption was assessed with an IPD meta-analysi
An assessment of the efficacy of treatment with acamprosate was, therefore, undertaken using meta-an...
Data on patients' alcohol consumption from 15 placebo-controlled treatment studies (n = 3309) were e...
Acamprosate is an FDA-approved medication that enhances abstinence in alcohol-dependent patients. A ...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Review on literature on the effect of anti-addictive substance in enhancing abstinence of dependent ...
Naturalistic randomised study controlled against any other treatment to assess the effect of acampro...
Method: Randomized parallel groups prospective trial to assess the efficacy of nursing follow up of...
Abstract — Standard treatment for alcohol abuse may include pharmacotherapy to alleviate withdrawal ...
We compared effects of the standard 2 g dose (n=258) and an exploratory 3 g dose of acamprosate (n=8...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addicti...
To assess the effectiveness of pharmacotherapy with acamprosate in alcohol-dependent patients treate...
We describe Efficacy and Safety of acamprosate in enhancing abstinence on detoxified patients, a met...
Acamprosate (calcium bis acetylhomotaurinate) is a new medication that appears to be clinically usef...
general study on compliance conditions throughout a meta-analysis of 4354 patients treated with acam...